tert-Butyl 3-bromopyrrolidine-1-carboxylate

Catalog No. :
ACTKLQ674
CAS No. :
939793-16-5
Molecular Formula :
C9H16BrNO2
Molecular Weight :
250.14

IUPAC Name:tert-butyl 3-bromopyrrolidine-1-carboxylate

tert-Butyl 3-bromopyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$65.00Login to see priceIn stockInquiry
25g98%$118.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromopyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-bromopyrrolidine-1-carboxylate
MDL No.MFCD08752478
Molecular FormulaC9H16BrNO2
Molecular Weight250.14
SMILESCC(C)(C)OC(=O)N1CCC(Br)C1
InChI KeyQJTKPXFJOXKUEY-UHFFFAOYSA-N
SynonymFT-0688658 | QJTKPXFJOXKUEY-UHFFFAOYSA-N | 2-Methyl-2-propanyl 3-bromo-1-pyrrolidinecarboxylate | 3-BROMO-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | 3-Bromopyrrolidine-1-carboxylic acid tert-butyl ester | DTXSID90655068 | J-504355 | N-Boc-3-Bromopyr
CAS No.939793-16-5
PubChem CID42614217

Safety Data

Pictogram
CorrosiveHarmful or irritantEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H318-H400
Precautionary Statement(s)
P264-P270-P273-P280-P301+P312+P330-P305+P351+P338-P337+P313-P391-P501

Synthetic Route by SureRoute

1. ACTKLQ674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKLQ674 route product structure diagram
    ACTKLQ674939793-16-5 In Stock
Inquiry

2. ACTKLQ674 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIRZF459 route compound structure diagram
    ACIRZF4591262769-75-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKLQ674 route product structure diagram
    ACTKLQ674939793-16-5 In Stock
Inquiry

Comments (0)